Interaction of Hemostatic Genetics With Hormone Therapy

This publication has 87 references indexed in Scilit:

• Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
  New England Journal of Medicine, 2000
• Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease
  New England Journal of Medicine, 2000
• Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
  JAMA, 1998
• Pla1/a2 polymorphism of glycoprotein IIIa and risk of coronary artery disease and restenosis following coronary angioplasty
  The American Journal of Cardiology, 1998
• The effects of transdermal oestradiol and oral progestogens on haemostasis variables
  BJOG: An International Journal of Obstetrics and Gynaecology, 1997
• Effects of Hormone-Replacement Therapy on Fibrinolysis in Postmenopausal Women
  New England Journal of Medicine, 1997
• Gender-Related Association Between β-Fibrinogen Genotype and Plasma Fibrinogen Levels and Linkage Disequilibrium at the Fibrinogen Locus in Greenland Inuit
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Mutation in blood coagulation factor V associated with resistance to activated protein C
  Nature, 1994
• Plasma fibrinogen in women: relationships with oral contraception, the menopause and hormone replacement therapy
  British Journal of Haematology, 1993
• Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial Hypercholesterolemia
  New England Journal of Medicine, 1990